JAZZ
Jazz Pharmaceuticals PLC
234.90$
-2.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +109.2% | +45.6% | +3.4% | +90.3% | +35.3% | +56.7% | +115.2% | +48.9% | +34.4% | +13.0% | +12.3% | +8.8% | +16.8% | +14.3% | +9.3% | +30.9% | +18.3% | +4.8% | +6.1% | +4.9% | |
| – | – | +62.3% | +27.8% | +56.4% | -30.8% | +40.7% | +2.8% | +462.5% | +30.2% | +15.0% | -12.7% | +2.8% | +4.6% | +10.3% | +5.3% | +16.4% | +196.0% | +22.6% | -19.4% | +2.3% | +12.9% | |
| – | – | +120.9% | +48.9% | -5.0% | +121.7% | +34.9% | +61.2% | +96.5% | +51.8% | +37.0% | +15.8% | +13.1% | +9.1% | +17.3% | +14.9% | +8.9% | +19.8% | +17.5% | +9.0% | +6.6% | +3.9% | |
| – | – | +20.0% | +27.0% | +0.2% | -47.7% | -29.9% | -44.9% | +45.0% | +127.7% | +82.7% | +58.8% | +20.0% | +22.3% | +14.2% | +32.3% | +11.9% | +50.8% | +16.7% | +43.9% | +4.0% | -11.5% | |
| – | – | +53.4% | -26.2% | +41.9% | -47.3% | +17.5% | +57.8% | +104.9% | +35.9% | +25.4% | +17.6% | +12.0% | +8.5% | +25.6% | +7.8% | +15.9% | +69.9% | -2.4% | -6.1% | +4.1% | +30.6% | |
| – | – | +21.3% | +68.3% | +14.7% | -54.1% | -0.4% | +27.4% | +137.3% | +38.8% | +100.0% | -17.0% | +10.8% | +23.9% | +17.9% | +30.0% | +22.3% | +35.2% | +28.2% | -11.4% | +3.1% | +21.8% | |
| – | – | – | – | – | – | +262.8% | +121.2% | +54.8% | +72.0% | -42.5% | +159.8% | +16.4% | -10.6% | +16.3% | -13.4% | -29.0% | -55.0% | -138.5% | – | +23.9% | -68.7% | |
| – | – | – | – | +44.7% | +15.5% | -44.2% | -86.8% | +907.1% | +59.6% | +95.8% | +8.0% | +8.8% | +25.5% | +1.0% | -7.9% | +38.0% | +179.6% | +3.4% | +0.4% | -17.7% | -18.1% | |
| – | – | – | – | – | – | – | +281.3% | +41.9% | +73.6% | -50.8% | +187.6% | +22.1% | -17.3% | +19.8% | -14.6% | -39.6% | -141.7% | – | – | +58.9% | -234.1% | |
| – | +12.9% | -166.6% | – | +91,018.8% | -47.9% | +9.9% | -88.6% | -3,043.2% | – | +2.8% | +12.9% | +27.1% | -135.3% | – | -191.3% | – | +544.8% | -173.4% | – | – | – | |
| – | – | – | – | – | – | – | +281.3% | +130.9% | -25.0% | -73.0% | +464.4% | +20.4% | +22.9% | -8.4% | +17.1% | -54.4% | -237.9% | – | – | +35.0% | -163.6% | |
| – | – | – | – | – | – | +116.6% | +147.9% | +130.8% | +46.4% | +28.5% | +14.1% | +13.2% | +3.3% | +19.7% | +8.6% | +3.1% | -1.5% | +42.9% | -1.3% | +5.0% | -92.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.